National Institute on Deafness and Other Communication Disorders; Notice of Meeting, 41074 [2021-16305]
Download as PDF
<![CDATA[
41074
Federal Register / Vol. 86, No. 144 / Friday, July 30, 2021 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Deafness and
Other Communication Disorders
Advisory Council.
This is a virtual meeting and will be
open to the public as indicated below.
The url link to this meeting is: https://
www.nidcd.nih.gov/about/advisorycouncil/upcoming-meetings. The
meeting is partially Closed to the public.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Deafness and
Other Communication Disorders Advisory
Council.
Date: September 9–10, 2021.
Closed: September 9, 2021, 10:00 a.m. to
12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Open: September 9, 2021, 1:00 p.m. to 3:10
p.m.
Agenda: Staff reports on divisional,
programmatical, and special activities.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Open: September 10, 2021, 10:00 a.m. to
12:00 p.m.
Agenda: Staff reports on divisional,
programmatical, and special activities.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Rebecca Wagenaar-Miller,
Ph.D., Director, Division of Extramural
Activities, NIDCD/NIH, 6001 Executive
Boulevard, Bethesda, MD 20892, (301) 496–
8693, rebecca.wagenaar-miller@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
VerDate Sep<11>2014
17:24 Jul 29, 2021
Jkt 253001
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nidcd.nih.gov/about/advisory-council,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
Dated: July 27, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–16305 Filed 7–29–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: SBIR/STTR Commercialization
Readiness Pilot Program.
Date: August 18, 2021.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Allen Richon, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6184,
MSC 7892, Bethesda, MD 20892, 301–379–
9351, allen.richon@nih.hhs.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
Dated: July 27, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–16307 Filed 7–29–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; PAR–19–202: High
Impact, Interdisciplinary Science in NIDDK
Research Areas (RC2)—Diabetes,
Endocrinology & Metabolic Diseases.
Date: September 20, 2021.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Lan Tian, Ph.D., Scientific
Review Officer, National Institute of Diabetes
and Digestive and Kidney Diseases, National
Institutes of Health, 6707 Democracy
Boulevard, Room 7349, Bethesda, MD 20892–
5452, (301) 496–7050, email: tianl@nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Review of
Institutional Training Grants in Digestive
Diseases and Nutrition.
Date: September 24, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Video
Meeting).
Contact Person: Lan Tian, Ph.D., Scientific
Review Officer, National Institute of Diabetes
and Digestive and Kidney Diseases, National
Institutes of Health, 6707 Democracy
Boulevard, Room 7349, Bethesda, MD 20892–
5452, (301) 496–7050, email: tianl@nih.gov.
E:\FR\FM\30JYN1.SGM
30JYN1
]]>Agencies
[Federal Register Volume 86, Number 144 (Friday, July 30, 2021)]
[Notices]
[Page 41074]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-16305]
[[Page 41074]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and Other Communication Disorders;
Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Deafness
and Other Communication Disorders Advisory Council.
This is a virtual meeting and will be open to the public as
indicated below. The url link to this meeting is: https://www.nidcd.nih.gov/about/advisory-council/upcoming-meetings. The meeting
is partially Closed to the public.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Deafness and Other Communication
Disorders Advisory Council.
Date: September 9-10, 2021.
Closed: September 9, 2021, 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Open: September 9, 2021, 1:00 p.m. to 3:10 p.m.
Agenda: Staff reports on divisional, programmatical, and special
activities.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Open: September 10, 2021, 10:00 a.m. to 12:00 p.m.
Agenda: Staff reports on divisional, programmatical, and special
activities.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: Rebecca Wagenaar-Miller, Ph.D., Director,
Division of Extramural Activities, NIDCD/NIH, 6001 Executive
Boulevard, Bethesda, MD 20892, (301) 496-8693, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://www.nidcd.nih.gov/about/advisory-council, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.173,
Biological Research Related to Deafness and Communicative Disorders,
National Institutes of Health, HHS)
Dated: July 27, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-16305 Filed 7-29-21; 8:45 am]
BILLING CODE 4140-01-P
